



The Asia International Hemp Expo & Forum 2026 (AIHEF 2026) and the Asia International Cannabis Expo & Forum 2026 (AICEF 2026) return as Asia's premier international platform dedicated to advancing the hemp and cannabis industries through innovation, knowledge exchange, and global collaboration.
Taking place from 18–20 November 2026 at the Queen Sirikit National Convention Center (QSNCC), Bangkok, Thailand, the event brings together policymakers, researchers, scientists, investors, manufacturers, healthcare professionals, entrepreneurs, and industry leaders from around the world.
The Forum will be held over two dedicated days, each focusing on a distinct industry sector:
-
18 November 2026 — Asia International Hemp Forum 2026
-
19 November 2026 — Asia International Cannabis Forum 2026
Each year, our international forums welcome distinguished speakers from across the globe to share cutting-edge research, industry insights, policy developments, investment opportunities, and commercial success stories. Whether your expertise lies in industrial hemp, medical cannabis, healthcare, manufacturing, research, technology, or international trade, we invite you to join Asia's leading platform for knowledge exchange and industry collaboration.

PROGRAMME AT A GLANCE
DAY 1 :
18 NOVEMBER 2026
ASIA INTERNATIONAL HEMP FORUM 2026
-
Strategic Forum I | The Next Hemp Economy
Why Global Industries Are Turning to Asia’s Emerging Hemp Market -
Strategic Forum II | Creating Demand, Building Supply
Solving the Industrial Hemp Commercialization Equation -
Strategic Forum III | From Fibre to High-Value Products
Commercializing Industrial Hemp Across Global Industries -
Strategic Forum IV | Hemp-Derived CBD: From Ingredient to Market
Developing Compliant Health, Wellness and Consumer Products -
Strategic Forum V | Medical Hemp: From Research to Commercial Application
Translating Cannabinoid Science into Health and Medical Solutions -
Strategic Forum VI | From Standard to Market
Industrial Hemp Compliance, Certification and Global Commercialization -
Strategic Forum VII | Scaling the Hemp Business
Investment, Trade and Cross-Border Market Development

DAY 2 :
19 NOVEMBER 2026
ASIA INTERNATIONAL CANNABIS FORUM 2026
-
Strategic Forum I | The Next Medical Cannabis Economy
Global Markets, Business Models and the Industries Positioned for Growth -
Strategic Forum II | The Asia Medical Cannabis Advantage
Building Thailand as a Regional Platform for Healthcare, Research and Commerce -
Strategic Forum III | From Patient Access to Commercial Scale
Building Medical Cannabis Markets Through Healthcare Integration -
Strategic Forum IV | From Science to Commercial Product
Turning Medical Cannabis Research into Scalable Products and Services -
Strategic Forum V | Compliance as a Commercial Advantage
Control Union Special Session & Interactive Workshop on Trade and Export Readiness -
Strategic Forum VI | The Next Cannabis Revolution
Science, Technology and Innovation Reshaping the Industry -
Strategic Forum VII | Building the Next Global Cannabis Market
Investment, Partnerships and Cross-Border Commercialization

PROGRAMME DETAILED
DAY 1 :
18 NOVEMBER 2026
ASIA INTERNATIONAL HEMP FORUM 2026
Strategic Forum I
“THE NEXT HEMP ECONOMY”
Why Global Industries Are Turning to Asia’s Emerging Hemp Market
Industrial Hemp is gaining attention across manufacturing, construction, textiles, food, health and sustainable materials. However, the next phase of development will depend on where new demand, investment and production capacity can be created.
This Strategic Forum will examine the commercial forces shaping the global Hemp industry and the role Thailand and Asia could play in its future development.
Key Discussion Areas
-
Global Industrial Hemp market development
-
Asia’s emerging role in the Hemp economy
-
Thailand as a regional production and manufacturing base
-
International investment and technology transfer
-
New market demand and cross-border partnerships
-
Commercial sectors with the strongest growth potential
Strategic Question
What will drive the next phase of the global Hemp economy, and where can Asia create competitive value?

Strategic Forum II
“CREATING DEMAND, BUILDING SUPPLY”
Solving the Industrial Hemp Commercialization Equation
The Hemp industry continues to face a fundamental challenge: producers require reliable demand, while manufacturers and buyers require stable supply, consistent quality and competitive pricing.
This Strategic Forum will explore practical commercial models that can connect farmers, processors, manufacturers, investors and buyers.
Key Discussion Areas
-
Demand creation and market development
-
Contract farming and commercial cultivation models
-
Offtake agreements and buyer commitments
-
Processing infrastructure and production capacity
-
Investment models for emerging Hemp markets
-
Technology transfer and international partnerships
-
Reducing supply-chain and market-entry risks
Strategic Question
How can supply, demand, investment and processing capacity be developed together?

Strategic Forum III
“FROM FIBRE TO HIGH-VALUE PRODUCTS”
Commercializing Industrial Hemp Across Global Industries
The future of Industrial Hemp will be determined by its ability to become a commercially competitive material and ingredient across multiple sectors.
This Strategic Forum will showcase the applications most likely to generate meaningful demand and attract manufacturing investment.
Key Application Areas
-
Hempcrete and sustainable construction
-
Insulation and building materials
-
Natural fibre composites
-
Automotive and mobility applications
-
Textiles and technical textiles
-
Sustainable fashion
-
Bioplastics and bio-based materials
-
Packaging
-
Hemp food and beverage ingredients
-
Nutraceutical and functional food products
Strategic Question
Which Hemp applications can create the strongest commercial demand and highest market value?

Strategic Forum IV
“HEMP-DERIVED CBD and Hemp Seed Oil: FROM INGREDIENT TO MARKET”
Developing Compliant Health, Wellness and Consumer Products
Hemp-derived CBD and Hemp Seed Oil have the potential to connect agriculture with the health, wellness, nutraceutical and consumer product industries.
Commercial success, however, requires more than cannabinoid production. It depends on product quality, formulation, safety, evidence, market positioning and regulatory compliance.
Key Discussion Areas
-
Global Hemp-derived CBD market development
-
CBD ingredients and finished products
-
Hemp Seed Oil ingredients and finished products
-
Nutraceuticals and dietary supplements
-
Functional food and wellness applications
-
Product formulation and delivery systems
-
Safety, testing and quality assurance
-
Consumer trust and responsible communication
-
Commercial pathways for Asian producers and brands
Strategic Question
How can Hemp-derived CBD be developed into trusted, compliant and commercially scalable products?

Strategic Forum V
“MEDICAL HEMP: FROM RESEARCH TO COMMERCIAL APPLICATION”
Translating Cannabinoid Science into Health and Medical Solutions
Medical Hemp and non-intoxicating cannabinoids are attracting increasing interest from researchers, healthcare professionals, pharmaceutical developers and wellness companies.
This Strategic Forum will examine how evidence-based research can support product development, healthcare applications and responsible commercialization.
Key Discussion Areas
-
CBD and non-intoxicating cannabinoid research
-
Hemp Seed Oil
-
Medical and therapeutic applications
-
Clinical and pre-clinical research
-
Pharmaceutical and nutraceutical development
-
Evidence-based product claims
-
New formulations and delivery technologies
-
Collaboration between research institutions and industry
-
Commercialization of science-led Hemp product
Strategic Question
What is required to move Medical Hemp from scientific research into credible products and real-world applications?

Strategic Forum VI
“FROM STANDARD TO MARKET”
Industrial Hemp Compliance, Certification and Global Commercialization
International buyers require more than production capacity. They require verified quality, traceability, consistency, sustainability and compliance with recognised standards.
This Strategic Forum will explore how certification and standards can support commercial credibility, buyer confidence and access to international markets.
Key Discussion Areas
-
Industrial Hemp compliance frameworks
-
Cultivation and processing standards
-
GACP and GMP principles
-
Fibre, textile and material specifications
-
Food and ingredient safety requirements
-
Product testing and quality assurance
-
Traceability and chain of custody
-
Sustainability and environmental certification
-
Audit readiness
-
Buyer qualification and export documentation
Strategic Question
Which standards and certification systems are needed to convert Hemp production into commercially accepted products?

Strategic Forum VII
“SCALING THE HEMP BUSINESS”
Investment, Trade and Cross-Border Market Development
The closing Strategic Forum will focus on how emerging Hemp businesses can progress from pilot projects and local production into sustainable, investable and internationally connected operations.
Key Discussion Areas
-
Commercial scale-up strategies
-
Investment and project financing
-
International trade models
-
Regional and global market access
-
Buyer and supplier partnerships
-
Manufacturing and processing investment
-
Technology licensing
-
Strategic joint ventures
-
Building commercially sustainable Hemp value chains
Strategic Question
What business models, investments and partnerships are needed to scale the Hemp industry across Asia?

PROGRAMME DETAILED
DAY 2 :
19 NOVEMBER 2026
ASIA INTERNATIONAL CANNABIS FORUM 2026
Strategic Forum I
“THE NEXT MEDICAL CANNABIS ECONOMY”
Global Markets, Business Models and the Industries Positioned for Growth
The global Cannabis industry is transitioning from early-stage market development toward more structured medical, pharmaceutical and healthcare-led models.
This Strategic Forum will identify the sectors, markets and commercial models most likely to shape the next phase of growth.
Key Discussion Areas
-
Global Medical Cannabis market development
-
Emerging and mature market comparisons
-
Pharmaceutical and healthcare business models
-
Patient-centred industry development
-
Cannabis-based medicines and wellness products
-
Investment priorities
-
International market expansion
-
The changing role of producers, brands and healthcare providers
Strategic Question
Which markets and business models will lead the next phase of the Medical Cannabis industry?

Strategic Forum II
“THE ASIA MEDICAL CANNABIS ADVANTAGE”
Building Thailand as a Regional Platform for Healthcare, Research and Commerce
Thailand combines medical infrastructure, research capability, agricultural expertise, tourism and regional connectivity.
This Strategic Forum will examine how these strengths could support a commercially sustainable Medical Cannabis ecosystem serving Thailand and the wider Asian market.
Key Discussion Areas
-
Thailand’s role within the Asian Medical Cannabis landscape
-
Healthcare and hospital integration
-
Medical and wellness tourism
-
Clinical research and product development
-
Regional manufacturing
-
Education and professional workforce development
-
International investment and joint ventures
-
Thailand as a gateway to emerging Asian markets
Strategic Question
How can Thailand build a credible regional platform for Medical Cannabis, healthcare and commercial development?

Strategic Forum III
“FROM PATIENT ACCESS TO COMMERCIAL SCALE”
Building Medical Cannabis Markets Through Healthcare Integration
Medical Cannabis cannot become a sustainable industry without an effective connection between patients, healthcare professionals, clinics, hospitals, products and responsible businesses.
This Strategic Forum will examine the commercial infrastructure required to convert medical demand into a structured and scalable market.
Key Discussion Areas
-
Patient access models
-
Role of doctors, clinics and hospitals
-
Medical assessment and treatment pathways
-
Product selection and responsible dispensing
-
Healthcare data and patient monitoring
-
Insurance and reimbursement considerations
-
Telemedicine and digital health
-
Medical distribution models
-
Commercial scale-up through healthcare systems
Strategic Question
How can patient access and healthcare integration create a responsible and commercially sustainable Medical Cannabis market?

Strategic Forum IV
“FROM SCIENCE TO COMMERCIAL PRODUCT”
Turning Medical Cannabis Research into Scalable Products and Services
Research alone does not build an industry. Commercialization requires evidence, product development, manufacturing, quality systems, market positioning and effective delivery to patients.
This Strategic Forum will explore the pathway from research and formulation to commercially viable Medical Cannabis products.
Key Discussion Areas
-
Research-driven product development
-
Clinical evidence and real-world data
-
Cannabis formulations and dosage forms
-
Pharmaceutical and herbal medicine development
-
Extraction and active ingredient production
-
Standardization and consistency
-
Intellectual property and technology licensing
-
Manufacturing scale-up
-
Product registration and market entry
-
Collaboration between researchers, healthcare providers and industry
Strategic Question
How can Medical Cannabis research be converted into trusted, scalable and commercially viable products?

Strategic Forum V
“COMPLIANCES SPECIAL SESSIONS ON TRADE & EXPORT”
Building Audit-Ready Cannabis Operations for Trade and Export
Compliance is not only a regulatory requirement. It is a critical commercial tool for building buyer confidence, reducing risk and accessing international markets.
Key Discussion Areas
-
GACP and cultivation compliance
-
GMP and post-harvest processing
-
Quality management systems
-
Traceability and chain of custody
-
Risk assessment
-
Supplier and facility qualification
-
Testing and product consistency
-
Audit preparation
-
Corrective action and continuous improvement
-
Export documentation
-
International buyer expectations
-
Building an export-ready compliance roadmap
Strategic Question
How can Cannabis businesses use compliance and certification to secure buyers, reduce commercial risk and enter international markets?

Strategic Forum VI
“THE NEXT CANNABIS REVOLUTION”
Science, Technology and Innovation Reshaping the Industry
The next phase of Cannabis development will be driven by more than cultivation and extraction. Science, healthcare technology, biotechnology and data will reshape how Cannabis products are developed, produced, prescribed and monitored.
Key Discussion Areas
-
Cannabinoid and terpene science
-
Minor cannabinoids
-
New extraction and purification technologies
-
Solventless processing
-
Advanced formulations and drug-delivery systems
-
Precision cultivation
-
Genetics and plant breeding
-
Artificial intelligence and data analytics
-
Digital health and telemedicine
-
Personalized and precision medicine
-
Biosynthesis and biotechnology
-
Testing and quality-control innovation
Strategic Question
Which technologies and scientific developments will transform the Cannabis industry over the next decade?

Strategic Forum VII
“BUILDING THE NEXT GLOBAL CANNABIS MARKET”
Investment, Partnerships and Cross-Border Commercialization
The final Strategic Forum will bring together the central themes of Medical Cannabis, compliance, innovation and market development.
The discussion will focus on the practical partnerships and investments required to connect Thailand and Asia with the wider global Cannabis economy.
Key Discussion Areas
-
International investment
-
Strategic partnerships and joint ventures
-
Cross-border trade
-
Technology transfer and licensing
-
Contract manufacturing
-
Medical product distribution
-
Certification and market access
-
Regional supply-chain development
-
Commercial collaboration between Asia and global markets
-
Priorities for long-term industry scale-up
Strategic Question
What partnerships, investments and commercial systems are needed to connect Asia with the next global Cannabis market?

Who Should Apply?
-
Researchers & Scientists
-
Medical Professionals & Healthcare Practitioners
-
University Academics
-
Government & Regulatory Representatives
-
Industry Experts
-
Entrepreneurs & Business Leaders
-
Manufacturers & Technology Providers
-
Investors & Venture Capital Representatives
-
Standards, Testing & Certification Bodies
-
International Organizations, Trade Associations & NGOs

Speaker Benefits
Selected speakers will receive exclusive event privileges, including:
-
Four (4) VIP Passes for your colleagues or guests
-
Business Matching Opportunities with international buyers, investors, government agencies, and strategic partners
-
Complimentary Lunch on your speaking day
-
Access to the VIP Business Lounge
-
Premium networking opportunities with delegates from across Asia and around the world
-
Official recognition as a speaker at one of Asia's leading hemp and cannabis forums

Submit Your Abstract
Join global thought leaders, researchers, innovators, policymakers, and business pioneers in shaping the future of the hemp and cannabis industries across Asia.
Whether your expertise is in science, medicine, sustainability, manufacturing, technology, policy, or international business, we invite you to share your knowledge and contribute to one of the region's most influential industry forums.
Submit your abstract and become part of the conversations driving the next generation of hemp and medical cannabis innovation.
Important Dates
Abstract Submission Deadline:
7 September 2026
Speaker Notification:
14 September 2026